Stock Research: Sawai Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Sawai Pharmaceutical

TSE:4555 JP3323050009
48
  • Value
    88
  • Growth
    34
  • Safety
    Safety
    53
  • Combined
    67
  • Sentiment
    22
  • 360° View
    360° View
    48
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sawai Group Holdings Co Ltd manufactures and sells medical and over-the-counter drugs. They operate in pharmaceutical and medical device manufacturing and sales, and R&D. Key regions include Japan and America. In the last fiscal year, the company had 3310 employees, a market cap of $1489 million, profits of $376 million, and revenue of $1261 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
88 86 92 100
Growth
34 59 39 51
Safety
Safety
53 61 72 70
Sentiment
22 86 82 25
360° View
360° View
48 98 98 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
61 40 44 28
Opinions Change
9 70 82 50
Pro Holdings
n/a 92 82 39
Market Pulse
53 65 54 44
Sentiment
22 86 82 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
88 86 92 100
Growth
34 59 39 51
Safety Safety
53 61 72 70
Combined
67 86 92 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
74 81 74 97
Price vs. Earnings (P/E)
75 76 91 97
Price vs. Book (P/B)
67 78 71 93
Dividend Yield
69 65 82 92
Value
88 86 92 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
44 36 37 43
Profit Growth
12 79 50 81
Capital Growth
64 34 18 24
Stock Returns
64 74 77 49
Growth
34 59 39 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
23 27 33 36
Refinancing
72 76 89 89
Liquidity
57 59 59 53
Safety Safety
53 61 72 70

Similar Stocks

Discover high‑ranked alternatives to Sawai Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Starts

TSE:8850
Country: Japan
Industry: Real Estate: Diversified Operations
Size: Medium
Full Stock Analysis

Kyudenko

TSE:1959
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Kumagai Gumi

TSE:1861
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: